SVP and CFO Thomas R Staab II sold $126K of BioCryst Pharmaceuticals, Inc.

Sold$126,325

$7.54Price

16,750Shares

−11%Stake

What BCRX did after the filing

Prices for BCRX after this filing aren't in yet.

Traded Thu, May 2. Filed Mon, May 6, 4:51 PM ET, after the close. Not investment advice.